Compare · ELV vs FTRE
ELV vs FTRE
Side-by-side comparison of Elevance Health Inc. (ELV) and Fortrea Holdings Inc. (FTRE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ELV and FTRE operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $80.93B, about 70.3x FTRE ($1.15B).
- Over the past year, ELV is down 9.1% and FTRE is up 94.4% - FTRE leads by 103.5 points.
- ELV has been more active in the news (8 items in the past 4 weeks vs 4 for FTRE).
- FTRE has more recent analyst coverage (25 ratings vs 22 for ELV).
PerformanceELV-9.10%FTRE+94.41%
2025-05-02+0.00%2026-05-01
- Company
- Elevance Health Inc.
- Fortrea Holdings Inc.
- Price
- $372.82-1.01%
- $12.17+5.83%
- Market cap
- $80.93B
- $1.15B
- 1M return
- +24.86%
- +28.24%
- 1Y return
- -9.10%
- +94.41%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 8
- 4
- Recent ratings
- 22
- 25
ELV
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest ELV
- Elevance Health Names Best in Class Primary Care Practices in Care Provider Recognition Program
- Elevance Health's Affiliated Health Plans Deliver More Predictable, Lower Healthcare Costs for Small Businesses
- Elevance Health upgraded by BofA Securities with a new price target
- SEC Form 10-Q filed by Elevance Health Inc.
- Elevance Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Elevance Health Reports First Quarter 2026 Results; Raises Full-Year Guidance
- Evercore ISI initiated coverage on Elevance Health with a new price target
- SEC Form PX14A6G filed by Elevance Health Inc.
- Elevance Health Announces Leadership Appointments to Strengthen Execution and Drive Growth
- Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2026 Results on April 22, 2026
Latest FTRE
- SEC Form DEFA14A filed by Fortrea Holdings Inc.
- SEC Form DEF 14A filed by Fortrea Holdings Inc.
- Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call
- Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials
- Amendment: SEC Form SCHEDULE 13G/A filed by Fortrea Holdings Inc.
- SEC Form 4 filed by Russell Erin L
- Chief Operating Officer Morais Mark A. sold $16,633 worth of shares (1,804 units at $9.22) and converted options into 4,284 shares, increasing direct ownership by 4% to 69,899 units (SEC Form 4)
- Chief Financial Officer Mcconnell Jill G. converted options into 4,284 shares and sold $16,633 worth of shares (1,804 units at $9.22), increasing direct ownership by 4% to 72,276 units (SEC Form 4)
- SEC Form 4 filed by Fortrea Holdings Inc.
- SEC Form 4 filed by Fortrea Holdings Inc.